Cardiology
Partner With Us
Advertisement
Conexiant chevron_right Cardiology chevron_right Invasive NSTEMI Strategy Shows No Benefit in Frail Patients
From the Journals

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management

Conexiant
article Full Article subject Summary summarize Notecard
  1. No benefit of invasive strategy on cardiovascular death or myocardial infarction.
  2. Higher frailty linked to potential harm with invasive care.
  3. Event rates numerically higher with invasive strategy.
  4. No differences in secondary outcomes.
  5. Supports frailty-guided treatment decisions.

Source: JAMA Network Open

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.